Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-center, Prospective, Open-label, Comparator Study, Blind for Central Accessor to Access the Efficacy, Safety, and Tolerability of Inhalations of Low-doses of Melphalan in Patients With Pneumonia With Confirmed or Suspected COVID-19

NCT04380376 is registered in ClinicalTrials.gov with Federal State Budgetary Institution, Pulmonology Scientific Research Institute as lead sponsor.

NCT NCT04380376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04380376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-center, Prospective, Open-label, Comparator Study, Blind for Central Accessor to Access the Efficacy, Safety, and Tolerability of Inhalations of Low-doses of Melphalan in Patients With Pneumonia With Confirmed or Suspected COVID-19
Lead sponsor
Federal State Budgetary Institution, Pulmonology Scientific Research Institute
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2020
Completion date
October 30, 2020
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, viral pneumonia